Four groups of PIP claimants most-likely to get ongoing £737 payments
More than 58 per cent of people claiming PIP for a visual disease have a monthly award of up to £737.20 for five years or more. More than half of all claimants with general musculoskeletal conditions ...
manilatimes1h
Capricor Therapeutics to Participate in Upcoming Investor Conferences
Capricor management will present updates on its lead program of deramiocel for the treatment of Duchenne muscular dystrophy (DMD) as well as provide other general scientific and corporate updates. For ...
Satellos Announces Completed Enrollment of all Four Multiple-Ascending Dose Cohorts for the Phase 1 Clinical Trial of SAT-3247 in Healthy Volunteers
Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle ...
Hosted on MSN20h
Derry man inspired by brother's struggle with "devastating" muscle wasting disease
Evan McMenamin said his brother Travis, "never lets it get him down" despite the "incredible challenges" he faces ...
manilatimes9h
Santhera Announces Chief Financial Officer Transition with Appointment of Catherine Isted
Current CFO Andrew Smith to step down after five years with Santhera, and will support an orderly transition ...
stmdailynews23h
What the ‘moral distress’ of doctors tells us about eroding trust in health care
The article discusses the ethical dilemmas faced by healthcare providers when families demand life-sustaining treatments for patients unlikely to benefit, highlighting moral distress and trust issues.